Story perspectives
Trump's Tariff Plan Threatens U.S. Drug Costs and Supply
4/9/2025
38 9
1 of 2
Trump's Tariff Initiative
- President Donald Trump has unveiled a bold plan to impose hefty tariffs on pharmaceutical imports, urging drug companies to bring their operations back to the U.S. This decision threatens to shake up global supply chains, especially impacting India's pharmaceutical industry, which provides 45% of U.S. generics. Experts caution that this could lead to soaring healthcare costs and possible drug shortages in America.
1 / 2
